Stocks
Dr. Reddy's Laboratories (RDY) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2022 | 2023 | 2024 | 2025 | 2026 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | -0.23 | -0.65 | -0.69 | -0.12 | -0.15 | -0.14 | |||
| Changes by years, y/y, % | +17% | +178% | +7% | -83% | +26% | +5.9% | |||
Dr. Reddy's Laboratories. Debt/EBITDA
Dr. Reddy's Laboratories. Debt/EBITDA, changes, %
Dr. Reddy's Laboratories (RDY) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q4 | 2026Q1 | 2026Q2 | 2026Q3 | 2026Q4 | LTM ? | |||
| Debt/EBITDA | -0.12 | -0.18 | -0.11 | -0.16 | -0.14 | -0.14 | ||
| Changes by years, y/y, % | -88% | -81% | -30% | +77% | +18% | |||
| Changes by quarters, q/q, % | +31% | +57% | -38% | +38% | -13% | |||
